Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Sidell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|March 16, 2002
Dopamine thioethers in neurodegenerationK R Sidell, V Amamath, T J Montine
Journal of Neurochemistry|June 1, 1999
The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulinM D Neely, K R Sidell, D G Graham, et al.
Journal of Neurochemistry|November 10, 2001
Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivoK R Sidell, S J Olson, J J Ou, et al.
Drug Metabolism Reviews|January 4, 2001
Dopamine mercapturate can augment dopaminergic neurodegenerationT J Montine, V Amarnath, M J Picklo, et al.
Lipids|February 1, 2000
Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivoC N Bassett, M D Neely, K R Sidell, et al.
Journal of Neuropathology and Experimental Neurology|May 22, 1998
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotypeK S Montine, E Reich, M D Neely, et al.
Neurology|October 26, 1999
Elevated CSF prostaglandin E2 levels in patients with probable ADT J Montine, K R Sidell, B C Crews, et al.
Journal of Neuropathology and Experimental Neurology|December 22, 1999
Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitisT Valyi-Nagy, K R Sidell, L J Marnett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|March 16, 2002
Dopamine thioethers in neurodegenerationK R Sidell, V Amamath, T J Montine
Journal of Neurochemistry|June 1, 1999
The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulinM D Neely, K R Sidell, D G Graham, et al.
Journal of Neurochemistry|November 10, 2001
Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivoK R Sidell, S J Olson, J J Ou, et al.
Drug Metabolism Reviews|January 4, 2001
Dopamine mercapturate can augment dopaminergic neurodegenerationT J Montine, V Amarnath, M J Picklo, et al.
Lipids|February 1, 2000
Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivoC N Bassett, M D Neely, K R Sidell, et al.
Journal of Neuropathology and Experimental Neurology|May 22, 1998
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotypeK S Montine, E Reich, M D Neely, et al.
Neurology|October 26, 1999
Elevated CSF prostaglandin E2 levels in patients with probable ADT J Montine, K R Sidell, B C Crews, et al.
Journal of Neuropathology and Experimental Neurology|December 22, 1999
Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitisT Valyi-Nagy, K R Sidell, L J Marnett, et al.
Pageof 1